期刊文献+

TRAIL分子胞外区基因工程蛋白的制备与鉴定

The cloning and expression of human outer-membrane region of TRAIL in E. Coli
下载PDF
导出
摘要 目的 制备人TRAIL配体胞外区基因工程蛋白。方法 应用RT PCR技术从激活的人外周血淋巴细胞总RNA中扩增TRAIL配体胞外区cDNA ,克隆入PCR2 .1 载体 ,测序验证后用基因重组法构建了TRAIL配体胞外区和组氨酸盒的原核表达质粒pQE hTRAIL。将重组质粒转入大肠杆菌M15中表达 ,经 1mmol LIPTG在 37℃条件下诱导 4h ,亲和层析柱纯化。用SDS -PAGE电泳和Westernblot鉴定表达产物。结果 所表达融合蛋白为人TRAIL配体胞外区分子 ,分子量 30kD。表达量约为 2mg ml。结论 人TRAIL配体胞外区在大肠杆菌中得到良好表达 ,为深入研究TRAIL配体分子在肿瘤与自身免疫病中的可能应用提供了材料。 Objective To obtain recombinant human outer-membrane region of TRAIL molecule.Methods RT-PCR was applied to amplify cDNA of outer-membrane region of TRAIL molecule from the total RNA extracted from activated human peripheral blood lymphocytes. The DNA fragment was cloned into PCR 2.1 vector. After sequencing, the cDNA of outer-membrane region of TRAIL molecule was inserted into pQE vector and expressed in E. Coli M15. The protein was purified through affinity chromatography column with ligand of 6 X His tag and identified by SDS-PAGE and Western Blotting.Results The protein expressed was purify with one band which was 30 KD analyzed by SDS-PAGE. The expressing protein was outer-membrane region of TRAIL molecule which identified by Western-blot.Conclusion The fusion human outer-membrane region of TRAIL molecule was obtained. It lays the foundation for the further studying.
出处 《中国实验诊断学》 2003年第6期477-479,共3页 Chinese Journal of Laboratory Diagnosis
基金 上海市高等学校科学技术发展基金项目No .O1BZ0 1
关键词 TRAIL分子胞外区 基因工程蛋白 制备 鉴定 TRAIL outer-membrane region fusion protein E.Coli expression
  • 相关文献

参考文献13

  • 1[1]Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induced apoptosis[ J ]. Immunity. 1995,3:672.
  • 2[2]Mariant SM, Krammer PH. Differential regulationof Trail and CD95 ligand in transformed cells of the T and B lymphocyte lineage[J]. Eur J Immunol, 1998,28:973.
  • 3[3]Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ et al. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells [J]. Immunol, 1998,161:2833.
  • 4[4]Pitti RM, Marsters SA, Ruppert S, et al. Induction of apoptosis by Apo2 ligand, a new member of the tumor necrosis factor cytokine family[ J].Biol. Chem, 1996,271:12687.
  • 5[5]Jeremias I, Herr I, Boehler T, Debatin KM. TRAIL/Apo-2-ligand induced apoptosis in human T cells[J]. Eur J Immunol, 1998, 28: 143.
  • 6[6]MacFarlane M, Ahmad M, Srinivasula SM, etal. Identification and molecular cloning of two novel receptors for the cytotoxic ligand Trail [ J ].Biol Chem, 1997, 272:25417.
  • 7[7]Degli-Esposti MA, Smolak PJ, Walczak H, et al. Cloning and characterization of Trail-R3, a vovel member of the emerging Trail receptor family [J]. Exp Med, 1997, 186:1165.
  • 8[8]Schneider P, Bodmer JL, Thome M, et al. Characterization of two receptors for Trail[J]. FEBS Lett, 1997, 416:329.
  • 9[9]Philips TA, Ni J, Pan G, et al, Trail (Apo2L) and Trail receptors in human placentas implications for immune privilege[J]. Immunol, 1999,162: 6053.
  • 10[10]Simon AK, Williams O, Mongkolsapaya J,et al. Tumor necrosis factor-related apoptosis-inducing ligand in T cell development:sensitivity of human thymocytes[J] .Proc Natl Acad Sci U S A,2001 ;98(9) :255.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部